137 related articles for article (PubMed ID: 31375598)
1. Getting insights into hepatocellular carcinoma tumour heterogeneity by multiomics dissection.
Sarobe P; Corrales F
Gut; 2019 Nov; 68(11):1913-1914. PubMed ID: 31375598
[No Abstract] [Full Text] [Related]
2. Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.
Marafin C; Rinaldi M; Angonese C; De Franchis G; Plebani M; Naccarato R; Farinati F
Ital J Gastroenterol; 1996 Dec; 28(9):493-8. PubMed ID: 9131393
[TBL] [Abstract][Full Text] [Related]
3. The Japanese approach to surgical treatment of hepatocellular carcinoma in liver cirrhosis: impressions of an Italian FPCR fellow.
Torzilli G
Jpn J Clin Oncol; 1997 Aug; 27(4):289-91. PubMed ID: 9379523
[No Abstract] [Full Text] [Related]
4. Pathology of liver cirrhosis and hepatocellular carcinoma. Recent studies by Japanese workers.
Mori W; Machinami R
Acta Pathol Jpn; 1982; 32 Suppl 1():133-43. PubMed ID: 6196936
[TBL] [Abstract][Full Text] [Related]
5. [Indications and results of liver transplantation in the treatment of hepatocellular carcinoma in cirrhosis].
Adam R; Castaing D; Azoulay D; Majno P; Samuel D; Bismuth H
Ann Chir; 1998; 52(6):547-57. PubMed ID: 9752505
[TBL] [Abstract][Full Text] [Related]
6. The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma.
Shen J; Huang CK; Yu H; Shen B; Zhang Y; Liang Y; Li Z; Feng X; Zhao J; Duan L; Cai X
J Cell Mol Med; 2017 May; 21(5):986-992. PubMed ID: 28224705
[TBL] [Abstract][Full Text] [Related]
7. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid hepatocellular-carcinoma showing rhabdomyoblastic differentiation in the adult cirrhotic liver.
Akasofu M; Kawahara E; Kaji K; Nakanishi I
Virchows Arch; 1999 Jun; 434(6):511-5. PubMed ID: 10394885
[TBL] [Abstract][Full Text] [Related]
9. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.
Granito A; Bolondi L
Lancet Oncol; 2017 Feb; 18(2):e101-e112. PubMed ID: 28214411
[TBL] [Abstract][Full Text] [Related]
10. [Treatments for hepatocellular carcinoma in cirrhosis : practical aspects].
Boudjema K
Ann Chir; 1998; 52(6):564-7. PubMed ID: 9752507
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis.
Melia WM; Wilkinson ML; Portmann BC; Johnson PJ; Williams R
Q J Med; 1984; 53(211):391-400. PubMed ID: 6207557
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for hepatocellular carcinoma with ultrasound and AFP is associated with improvements in tumour detection, receipt of curative therapy and overall survival in patients with cirrhosis.
Bischof DA; Pawlik TM
Evid Based Med; 2014 Dec; 19(6):225-6. PubMed ID: 25081827
[No Abstract] [Full Text] [Related]
13. Hepatocellular carcinoma and chronic persistent hepatitis.
Shikata T; Yamazaki S; Uzawa T
Acta Pathol Jpn; 1977 May; 27(3):297-304. PubMed ID: 200057
[TBL] [Abstract][Full Text] [Related]
14. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case.
Ishida M; Seki K; Tatsuzawa A; Katayama K; Hirose K; Azuma T; Imamura Y; Abraham A; Yamaguchi A
Surg Today; 2003; 33(3):214-8. PubMed ID: 12658390
[TBL] [Abstract][Full Text] [Related]
15. [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].
Takezaki E; Murakami S; Kagawa K; Omori H; Nishibayashi H
Gan No Rinsho; 1990 Jan; 36(1):19-22. PubMed ID: 2153846
[TBL] [Abstract][Full Text] [Related]
16. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.
Akagi G; Furuya K; Kanamura A; Chihara T; Otsuka H
Cancer; 1984 Jul; 54(2):315-8. PubMed ID: 6202391
[TBL] [Abstract][Full Text] [Related]
17. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
18. Liver cell atypias: a comparative study in cirrhosis with and without hepatocellular carcinoma.
Ojanguren I; Castellà E; Ariza A; Santos J; Planas R; Bruguera M
Histopathology; 1997 Feb; 30(2):106-12. PubMed ID: 9067732
[TBL] [Abstract][Full Text] [Related]
19. The ether lipid tumour marker in human liver with hepatocellular carcinoma.
Lin HJ; Wu PC; Ho JC
Br J Cancer; 1980 Feb; 41(2):320-4. PubMed ID: 6245673
[No Abstract] [Full Text] [Related]
20. Review article: liver transplantation for hepatocellular carcinoma.
Steinmüller T; Jonas S; Neuhaus P
Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():138-44. PubMed ID: 12786625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
